Pharmaceuticals
Enabling quick and smart access to Pharmaceuticals ingredients, we bring API expertise with a worldwide sourcing, and have a certified Excipients experience. Either you are looking for Veterinary API’s, Human API’s, Excipients, API Impurities, you can find them quickly by browsing our online catalog.
Pharmaceuticals
293
results for
Pharmaceuticals
Filters
Refine your search
Excipient for use in pharmaceutical applications. It acts as a preservative.
TDS
Excipient developed for injectable formulations. It functions as a preservative/antimicrobial. Benefits:
- Maintains a low level of endotoxins with the bioburden limits (BET/MLT etc)
TDS
Excipiteent having possible use in pharmaceutical applications.
TDS
Excipient developed for pharmaceutical applications. It acts as an antioxidant.
TDS
Excipient for pharmaceutical applications such as solid and semi-solid dosage forms.Benefits:
- DMF filed excipient - CDE # F20200000188
- All peak positions are within 5cm-1cm of those determined for 3-tert-Butyl-4-hydroxyanisole standard
TDS
Excipient for use in pharmaceutical applications. It acts as an antioxidant.
TDS
Excipient for pharmaceutical applications such as solid and semi-solid dosage forms.Benefits:
- DMF filed excipient - CDE # F20200000188
- All peak positions are within 5cm-1cm of those determined for 3-tert-Butyl-4-hydroxyanisole standard
TDS
Excipient specially developed for solid and semi-solid dosage forms. It is an antioxidant and reducing agent used in injectable formulations.Benefits:
- Maintains low level of endotoxins with the bioburden limits (BET/MLT etc)
- DMF Filed - CDE # F20200000189
TDS
Antioxidant and reducing agent used in injectable formulations. t is an excipient designed for solid and semi-solid dosage forms. Benefits:
- Maintains low level of endotoxins with the bioburden limits (BET/MLT etc)
- DMF Filed - CDE # F20200000189
TDS
Excipient designed for solid and semi-solid dosage forms. Antioxidant and reducing agent developed for injectable formulations.Benefits:
- DMF Filed - CDE # F20200000189
- Maintains low level of endotoxins with the bioburden limits (BET/MLT etc)
TDS
Excipient specially developed for solid and semi-solid dosage forms. It is an antioxidant and reducing agent used in injectable formulations.Benefits:
- Maintains low level of endotoxins with the bioburden limits (BET/MLT etc)
- DMF Filed - CDE # F20200000189
TDS
Actylis
Actylis is a leading manufacturer and supplier of critical raw materials and performance ingredients serving the Life Sciences, Specialty Chemicals, and Agriscience industries.
